GAIN THERAPEUTICS INC
2.1037
07-October-24 13:03:46
15 minutes delayed
Stocks
+0.2837
+15.59%
Today's range
1.8260 - 2.1200
ISIN
N/A
Source
NASDAQ
-
01 Apr 2024 08:25:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
26 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Present at Public Ventures Discovery Day
15 Mar 2024 13:30:34 By Nasdaq GlobeNewswire
-
Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight
14 Feb 2024 11:29:34 By Nasdaq GlobeNewswire
-
06 Feb 2024 08:56:04 By Nasdaq GlobeNewswire
-
06 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
31 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
02 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research
04 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
01 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in AI Driven Drug Discovery Summit
29 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
24 Nov 2023 12:01:00 By Nasdaq GlobeNewswire
-
21 Nov 2023 07:54:48 By Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Proposed Public Offering
20 Nov 2023 15:03:43 By Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
14 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023
25 Sep 2023 15:05:00 By Nasdaq GlobeNewswire
-
20 Sep 2023 15:05:00 By Nasdaq GlobeNewswire